Canada markets close in 59 minutes

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.2050+0.0250 (+1.15%)
As of 02:57PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 29.83M
Enterprise Value -13.81M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.69
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.95

Trading Information

Stock Price History

Beta (5Y Monthly) 1.78
52-Week Change 3-8.44%
S&P500 52-Week Change 3-15.72%
52 Week High 32.5900
52 Week Low 31.7100
50-Day Moving Average 32.0696
200-Day Moving Average 32.2668

Share Statistics

Avg Vol (3 month) 326.76k
Avg Vol (10 day) 316.09k
Shares Outstanding 514.41M
Implied Shares Outstanding 6N/A
Float 810.96M
% Held by Insiders 10.74%
% Held by Institutions 138.64%
Shares Short (Nov 14, 2022) 450.51k
Short Ratio (Nov 14, 2022) 42.31
Short % of Float (Nov 14, 2022) 40.43%
Short % of Shares Outstanding (Nov 14, 2022) 40.35%
Shares Short (prior month Oct 13, 2022) 455.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 03, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:18
Last Split Date 3Apr 03, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.57%
Return on Equity (ttm)-29.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.92M
Net Income Avi to Common (ttm)-14.43M
Diluted EPS (ttm)-1.2830
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)43.94M
Total Cash Per Share (mrq)3.05
Total Debt (mrq)409k
Total Debt/Equity (mrq)0.96
Current Ratio (mrq)23.00
Book Value Per Share (mrq)2.96

Cash Flow Statement

Operating Cash Flow (ttm)-14.37M
Levered Free Cash Flow (ttm)-8.57M